Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Pediatric Emergency Care
|
April 23, 2015
Necrotizing Fasciitis of the Chest Wall: Report of Pediatric Cases
Monica Kumar, Andrew Meeks, Liza Kearl
Seminars in Arthritis and Rheumatism
|
July 27, 2015
Pregnancy outcomes following exposure to abatacept during pregnancy
Monica Kumar, Laura Ray, Sudha Vemuri, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 24, 2025
Basic Science and Pathogenesis
Isha Verma, Monica Kumar, Kirpal Bains, et al.
Pediatrics
|
August 3, 2006
Comparison of accidental and nonaccidental traumatic head injury in children on noncontrast computed tomography
Glenn A Tung, Monica Kumar, Randal C Richardson, et al.
Journal of the International AIDS Society
|
November 14, 2014
Nephrolithiasis and renal failure among patients exposed to atazanavir, other PIs and PI-free regimens
Ella Nkhoma, Monica Kumar, Patricia Hines, et al.
The Journal of Comparative Neurology
|
June 1, 2006
Central projections of melanopsin-expressing retinal ganglion cells in the mouse
Samer Hattar, Monica Kumar, Alexander Park, et al.
Orphanet Journal of Rare Diseases
|
April 25, 2023
Olipudase alfa enzyme replacement therapy for acid sphingomyelinase deficiency (ASMD): sustained improvements in clinical outcomes after 6.5 years of treatment in adults
Robin H Lachmann, George A Diaz, Melissa P Wasserstein, et al.
Genetics in Medicine Open
|
December 13, 2024
The impact of sphingomyelin on the pathophysiology and treatment response to olipudase alfa in acid sphingomyelinase deficiency
Monica Kumar, Mario Aguiar, Andreas Jessel, et al.
Orphanet Journal of Rare Diseases
|
March 15, 2023
Correction : Long-term safety and clinical outcomes of olipudase alfa enzyme replacement therapy in pediatric patients with acid sphingomyelinase deficiency: two-year results
George A Diaz, Roberto Giugliani, Nathalie Gufon, et al.
Orphanet Journal of Rare Diseases
|
December 14, 2022
Long-term safety and clinical outcomes of olipudase alfa enzyme replacement therapy in pediatric patients with acid sphingomyelinase deficiency: two-year results
George A Diaz, Roberto Giugliani, Nathalie Guffon, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Pediatric Emergency Care
|
April 23, 2015
Necrotizing Fasciitis of the Chest Wall: Report of Pediatric Cases
Monica Kumar, Andrew Meeks, Liza Kearl
Seminars in Arthritis and Rheumatism
|
July 27, 2015
Pregnancy outcomes following exposure to abatacept during pregnancy
Monica Kumar, Laura Ray, Sudha Vemuri, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 24, 2025
Basic Science and Pathogenesis
Isha Verma, Monica Kumar, Kirpal Bains, et al.
Pediatrics
|
August 3, 2006
Comparison of accidental and nonaccidental traumatic head injury in children on noncontrast computed tomography
Glenn A Tung, Monica Kumar, Randal C Richardson, et al.
Journal of the International AIDS Society
|
November 14, 2014
Nephrolithiasis and renal failure among patients exposed to atazanavir, other PIs and PI-free regimens
Ella Nkhoma, Monica Kumar, Patricia Hines, et al.
The Journal of Comparative Neurology
|
June 1, 2006
Central projections of melanopsin-expressing retinal ganglion cells in the mouse
Samer Hattar, Monica Kumar, Alexander Park, et al.
Orphanet Journal of Rare Diseases
|
April 25, 2023
Olipudase alfa enzyme replacement therapy for acid sphingomyelinase deficiency (ASMD): sustained improvements in clinical outcomes after 6.5 years of treatment in adults
Robin H Lachmann, George A Diaz, Melissa P Wasserstein, et al.
Genetics in Medicine Open
|
December 13, 2024
The impact of sphingomyelin on the pathophysiology and treatment response to olipudase alfa in acid sphingomyelinase deficiency
Monica Kumar, Mario Aguiar, Andreas Jessel, et al.
Orphanet Journal of Rare Diseases
|
March 15, 2023
Correction : Long-term safety and clinical outcomes of olipudase alfa enzyme replacement therapy in pediatric patients with acid sphingomyelinase deficiency: two-year results
George A Diaz, Roberto Giugliani, Nathalie Gufon, et al.
Orphanet Journal of Rare Diseases
|
December 14, 2022
Long-term safety and clinical outcomes of olipudase alfa enzyme replacement therapy in pediatric patients with acid sphingomyelinase deficiency: two-year results
George A Diaz, Roberto Giugliani, Nathalie Guffon, et al.
Page
of 2